<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00580892</url>
  </required_header>
  <id_info>
    <org_study_id>NIH/LAMMP-2006-4982</org_study_id>
    <nct_id>NCT00580892</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography of Airway and Pleural Disorders</brief_title>
  <official_title>Optical Coherence Tomography of Airway and Pleural Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beckman Laser Institute University of California Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researcher can use Optical coherence tomography a near-infrared diode to emit light that
      can produce images of the specimen under investigation and provide information about tissue
      abnormalities without causing damage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The researcher can use Optical coherence tomography endoscopic imaging to improve diagnosis
      and treatment of airway and pleural malignancy. In the events of burn injury and smoke
      inhalation injury, the Optical coherence tomography can determine the change of the airway
      tissues and severity of airway injury.

      During endoscopic procedure the lesions will be biopsied and prepared by standard histologic
      methods. The Optical coherence tomography endoscopic imaging can measured histologic of the
      tissue samples and compared to standard histologic examination. The Optical coherence
      tomography endoscopic imaging can measured the epithelial thickness and compared to visual
      inspection of the mucosa on bronchoscopy.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Not a clinical trial study
  </why_stopped>
  <start_date>July 2007</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>histopathology</measure>
    <time_frame>up to 4 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Disorder of Pleura and Pleural Cavity</condition>
  <arm_group>
    <arm_group_label>Airway and Pleural Disorders</arm_group_label>
    <description>Optical Coherence Tomography imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Coherence Tomography imaging</intervention_name>
    <description>Optical Coherence Tomography imaging</description>
    <arm_group_label>Airway and Pleural Disorders</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will be selcted from University of California Irvine Chao Cancer Center.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult 18 or older, male or female.

          -  Plans for bronchoscopic with possible biopsy procedures.

        Exclusion Criteria:

          -  Age less than 18 years of age

          -  Not plan for bronchoscopic with possible biopsy procedures.

          -  Pregnant or breastfeeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Brenner, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pulmonary and Critical Care Medicine</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2007</study_first_submitted>
  <study_first_submitted_qc>December 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 27, 2007</study_first_posted>
  <last_update_submitted>August 23, 2017</last_update_submitted>
  <last_update_submitted_qc>August 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Beckman Laser Institute and Medical Center</investigator_full_name>
    <investigator_title>Matthew Brenner, M.D.,Department of Pulmonary and Critical Care Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Pleural Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

